Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated By Epigenetic Plasticity of Residual Disease and By-Pass Signaling Via MAPK Pathway
Lodovico Terzi di Bergamo(Institute of Oncology Research), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Jakob Passweg(University Hospital of Basel), Alessandra Tedeschi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesco Passamonti(University of Milan), Claudio Martines(International Centre for Genetic Engineering and Biotechnology), Georg Stüssi(Institute of Oncology Research), Antonella Zucchetto(Centro di Riferimento Oncologico), Adalgisa Condoluci(Ente Ospedaliero Cantonale), Dimitar G. Efremov(Macedonian Academy of Sciences and Arts), Lorenzo De Paoli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hossein Khiabanian(Rutgers, The State University of New Jersey), Tamara Bittolo(Centro di Riferimento Oncologico), Maria Cristina Pirosa(Institute of Oncology Research), Marina Deodato(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Francesco Autore(Agostino Gemelli University Polyclinic), Luca Laurenti(Sapienza University of Rome), Lydia Scarfò(IRCCS Ospedale San Raffaele), Elisa Civanelli(Institute of Oncology Research), Erika Tissino(Centro di Riferimento Oncologico), Bernhard Gerber, Marco Montillo(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alexandar Tzankov(University of Basel), Deborah Piffaretti(Institute of Oncology Research), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Franco Cavalli(Institute of Social and Preventive Medicine), Katia Pini(Institute of Oncology Research), Silvia Rasi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Matin Salehi(SIB Swiss Institute of Bioinformatics), Jui Wan Loh(Southwestern Medical Center), Michele Merli(University of Insubria), Chiara Tarantelli(Institute of Oncology Research), Francesco Bertoni(Ente Ospedaliero Cantonale), Anna Maria Frustaci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Gabriela Forestieri(Institute of Oncology Research), Amartya Singh(Rutgers, The State University of New Jersey), Valter Gattei(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Clara Deambrogi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Paolo Ghia(Vita-Salute San Raffaele University), Simone Bocchetta(Institute of Oncology Research), Ilaria Romano(University of Padua), Emanuele Zucca(Università della Svizzera italiana), Michael Gregor(University of Lucerne), Valeria Spina(Ente Ospedaliero Cantonale), Federico Jauk(Institute of Oncology Research), G. Galimberti(Institute of Oncology Research), Alessio Bruscaggin(Institute of Oncology Research)
Cited by 4
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k